Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vir Biotechnology Inc V.VIR


Primary Symbol: VIR

Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.


NDAQ:VIR - Post by User

Comment by theshadow39on Mar 20, 2019 10:35pm
56 Views
Post# 29514775

RE:RE:this one could get explosive!

RE:RE:this one could get explosive!Hi CMJ

good points re the greenhouse, that is a large construction and won’t be licensed for quite sometime. I would prefer to see a small scalable model that can be producing a crop ASAP. 

build a small potion - staff - work out the kinks - repeat. 

I have noticed that they took the greenhouse off the website. And their Investor email today references growing the canopy with minimal capital expense. 

I do have to disagree with you on the initial sales numbers being poor.  They barely had their sales licence in 2018 and they sold purely wholesale.  I will be interested to see those numbers with some retail thrown into the mix.  And I bet we see that soon as they are selling in Bc and have an agreeemebt for Saskatchewan. 
<< Previous
Bullboard Posts
Next >>